Amgen (0R0T) Share Forecast & Price Target
0R0T Analyst Ratings
Moderate Buy
9Buy16Hold2Sell
Based on 27 analysts giving stock ratings to Amgen in the past 3 months
0R0T Stock 12 Month Forecast
Average Price Target
$406.71▼(-12.88% Downside)Based on 27 Wall Street analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is $406.71 with a high forecast of $500.00 and a low forecast of $230.00. The average price target represents a -12.88% change from the last price of $466.85.
Past 12 Months12 Month ForecastDec2025Sep2026
High$500.00
Average$406.71
Low$230.00
Highest Price TargetHighest$500.00Average Price Target$406.71Lowest Price TargetLowest$230.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Geoff Meacham | Citi | $405 | hold | -13.25%Downside | Reiterated | 10/27/26 | ||
| Luca Issi | RBC Capital | $430 | buy | -7.89%Downside | Reiterated | 10/27/26 | ||
| Mohit Bansal | Wells Fargo | $430 | hold | -7.89%Downside | Reiterated | 10/27/26 | ||
| Emily Field | Barclays | $400 | hold | -14.32%Downside | Reiterated | 10/26/26 | ||
| Tazeen Ahmad | Bank of America Securities | $328 | sell | -29.74%Downside | Reiterated | 10/26/26 | ||
| David Amsellem | Piper Sandler | $457 | buy | -2.11%Downside | Reiterated | 10/26/26 | ||
| Yaron Werber | TD Cowen | $452 | buy | -3.18%Downside | Reiterated | 10/26/26 | ||
| Louise Chen | Scotiabank | $500 | buy | 7.10%Upside | Reiterated | 10/26/26 | ||
| Courtney Breen | Bernstein | $345 | hold | -26.10%Downside | Reiterated | 10/25/26 | ||
| Salveen Richter | Goldman Sachs | $450→$481 | buy | 3.03%Upside | Reiterated | 10/25/26 | ||
| Michael Yee | UBS | $470 | buy | 0.68%Upside | Reiterated | 10/24/26 | ||
| Jay Olson | Oppenheimer | $450→$480 | buy | 2.82%Upside | Assigned | 10/23/26 | ||
| Evan Seigerman | BMO Capital | $450→$415 | hold | -11.11%Downside | Reiterated | 10/12/26 | ||
| Vamil Divan | Guggenheim | $388→$378 | hold | -19.03%Downside | Reiterated | 10/12/26 | ||
| Carter Gould | Cantor Fitzgerald | $400→$440 | hold | -5.75%Downside | Assigned | 10/08/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Geoff Meacham | 10/27/26 | $405 | hold | -13.25%Downside | Reiterated | Citi | ||
| Luca Issi | 10/27/26 | $430 | buy | -7.89%Downside | Reiterated | RBC Capital | ||
| Mohit Bansal | 10/27/26 | $430 | hold | -7.89%Downside | Reiterated | Wells Fargo | ||
| Emily Field | 10/26/26 | $400 | hold | -14.32%Downside | Reiterated | Barclays | ||
| Tazeen Ahmad | 10/26/26 | $328 | sell | -29.74%Downside | Reiterated | Bank of America Securities | ||
| David Amsellem | 10/26/26 | $457 | buy | -2.11%Downside | Reiterated | Piper Sandler | ||
| Yaron Werber | 10/26/26 | $452 | buy | -3.18%Downside | Reiterated | TD Cowen | ||
| Louise Chen | 10/26/26 | $500 | buy | 7.10%Upside | Reiterated | Scotiabank | ||
| Courtney Breen | 10/25/26 | $345 | hold | -26.10%Downside | Reiterated | Bernstein | ||
| Salveen Richter | 10/25/26 | $450→$481 | buy | 3.03%Upside | Reiterated | Goldman Sachs | ||
| Michael Yee | 10/24/26 | $470 | buy | 0.68%Upside | Reiterated | UBS | ||
| Jay Olson | 10/23/26 | $450→$480 | buy | 2.82%Upside | Assigned | Oppenheimer | ||
| Evan Seigerman | 10/12/26 | $450→$415 | hold | -11.11%Downside | Reiterated | BMO Capital | ||
| Vamil Divan | 10/12/26 | $388→$378 | hold | -19.03%Downside | Reiterated | Guggenheim | ||
| Carter Gould | 10/08/26 | $400→$440 | hold | -5.75%Downside | Assigned | Cantor Fitzgerald |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Amgen
3 Months
Success Rate16/21 ratings generated profit
76%
Average Return
+6.48%
Copying David Amsellem's trades and holding each position for 3 Months would result in 76.19% of your transactions generating a profit, with an average return of +6.48% per trade.
1 Year
Success Rate21/21 ratings generated profit
100%
Average Return
+27.02%
Copying David Amsellem's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +27.02% per trade.
2 Years
Success Rate21/21 ratings generated profit
100%
Average Return
+40.60%
Copying David Amsellem's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +40.60% per trade.
0R0T Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 26 | 19 | 24 | 34 | 41 |
| Hold | 27 | 22 | 26 | 39 | 47 |
| Sell | 2 | 2 | 3 | 5 | 6 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 55 | 43 | 53 | 78 | 94 |
In the current month, 0R0T has received 41 Buy Ratings, 47 Hold Ratings, and 6 Sell Ratings. 0R0T average Analyst price target in the past 3 months is 406.71.
0R0T Financial Forecast
High$6.09
Consensus$5.79
Low$5.47
0R0T Earnings Forecast
Next quarter’s earnings estimate for 0R0T is $5.79 with a range of $5.47 to $6.09. The previous quarter’s EPS was $6.29. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$10.3B
Consensus$10.1B
Low$9.85B
0R0T Sales Forecast
Next quarter’s sales forecast for 0R0T is $10.07B with a range of $9.85B to $10.28B. The previous quarter’s sales results were $10.07B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
0R0T Stock Forecast FAQ
What is GB:0R0T’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen’s 12-month average price target is $406.71.
What is GB:0R0T’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0R0T, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Amgen a Buy, Sell or Hold?
Amgen has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 16 hold ratings and 2 sell ratings.
What is Amgen’s share price target?
The average share price target for Amgen is $406.71. This is based on 27 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $500.00, and the lowest forecast is $230.00. The average share price target represents a 12.88% decrease from the current price of $466.845.
What do analysts say about Amgen?
Amgen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 27 Wall Street analysts.
How can I buy shares of Amgen?
To buy shares of GB:0R0T, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.